We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
(-25%)
Cap. Flow
-$209M
Cap. Flow
% of AUM
-30.05%
Top 10 Holdings %
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$2.36M |
| 2 |
Collegium Pharmaceutical
COLL
|
+$2.32M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$2.29M |
| 4 |
HSII
Heidrick & Struggles
HSII
|
+$2.25M |
| 5 |
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
|
+$2.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emergent Biosolutions
EBS
|
+$5.99M |
| 2 |
Commercial Metals
CMC
|
+$5.95M |
| 3 |
Benchmark Electronics
BHE
|
+$5.84M |
| 4 |
Upbound Group
UPBD
|
+$5.71M |
| 5 |
FreightCar America
RAIL
|
+$5.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.04% |
| 2 | Industrials | 15.17% |
| 3 | Technology | 12.86% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Financials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Mercury Systems
MRCY
$6.15B
| $774K | 0.11% |
38,135
-35,224
| -48% | -$616K |
|
|
SALE
327
DELISTED
RetailMeNot, Inc. Series 1
SALE
| $774K | 0.11% |
+96,591
| New | +$787K |
|
328
Group 1 Automotive
GPI
$4.03B
| $773K | 0.11% |
13,173
-35,310
| -73% | -$2.02M |
|
|
MRD
329
DELISTED
MEMORIAL RESOURCE DEV CORP COM STK (DE)
MRD
| $773K | 0.11% |
+75,900
| New | +$898K |
|
330
Village Super Market
VLGEA
$642M
| $771K | 0.11% |
31,893
+17,885
| +128% | +$443K |
|
|
CNR
331
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $770K | 0.11% |
54,208
-10,768
| -17% | -$120K |
|
332
Hovnanian Enterprises
HOV
$786M
| $766K | 0.11% |
19,632
+18,225
| +1,295% | +$690K |
|
333
Strategic Education
STRA
$1.78B
| $761K | 0.11% |
+15,619
| New | +$770K |
|
334
Blackbaud
BLKB
$1.62B
| $758K | 0.11% |
+12,056
| New | +$705K |
|
|
KND
335
DELISTED
Kindred Healthcare
KND
| $756K | 0.11% |
61,199
-39,615
| -39% | -$411K |
|
336
Piper Sandler
PIPR
$5.13B
| $755K | 0.11% |
60,900
-22,564
| -27% | -$228K |
|
|
IPHS
337
DELISTED
Innophos Holdings, Inc.
IPHS
| $753K | 0.11% |
+24,372
| New | +$671K |
|
338
Itron
ITRI
$3.69B
| $752K | 0.11% |
+18,018
| New | +$666K |
|
|
PBPB
339
DELISTED
Potbelly
PBPB
| $748K | 0.11% |
+54,960
| New | +$659K |
|
|
WIRE
340
DELISTED
Encore Wire Corp
WIRE
| $748K | 0.11% |
+19,205
| New | +$696K |
|
|
CALD
341
DELISTED
Callidus Software, Inc.
CALD
| $746K | 0.11% |
44,717
+11,591
| +35% | +$172K |
|
|
SKUL
342
DELISTED
SKULLCANDY INC
SKUL
| $741K | 0.11% |
208,155
+176,988
| +568% | +$637K |
|
343
Nelnet
NNI
$4.82B
| $740K | 0.11% |
18,784
-68,994
| -79% | -$2.41M |
|
344
Rayonier Advanced Materials
RYAM
$558M
| $731K | 0.11% |
76,911
+51,397
| +201% | +$405K |
|
|
STL
345
DELISTED
Sterling Bancorp
STL
| $728K | 0.1% |
+45,676
| New | +$692K |
|
346
Magnite
MGNI
$2.78B
| $727K | 0.1% |
+39,790
| New | +$609K |
|
347
DHT Holdings
DHT
$2.94B
| $720K | 0.1% |
124,918
+45,101
| +57% | +$268K |
|
348
Strategy Inc
MSTR
$35.8B
| $720K | 0.1% |
40,090
-123,850
| -76% | -$2.01M |
|
|
EE
349
DELISTED
El Paso Electric Company
EE
| $720K | 0.1% |
+15,684
| New | +$645K |
|
|
FFG
350
DELISTED
FBL Financial Group
FFG
| $718K | 0.1% |
+11,671
| New | +$687K |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q1 2016 Portfolio in Review
As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.
Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.
- TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
- TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
- TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
- TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
- TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
- TFS Capital opened 502 new positions and closed 257 in Q1 2016.
- TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.
Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.